Aurinia Pharmaceuticals (AUPH) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Aurinia Pharmaceuticals (AUPH) Company Statistics | The Fly

Aurinia Pharmaceuticals

· AUPH

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

2.185 B

-1.37%

General

Market Cap: $2.18B
Enterprise Value: $1.96B
Shares Outstanding: 128,600,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 90.36%
Operating Margin: 48.39%
Net Profit Margin: 100.84%
FCF Margin: 55.72%
ROA: 39.65%
ROE: 59.00%
ROIC: 21.27%
Current Ratio: 5.42
Debt-to-Equity: 0.10
Revenue Per Employee: —

Valuation (TTM)

P/E: 6.71
PEG: 0.02
P/S: 6.69
P/FCF: 12.00
P/B: 3.39
EV/EBITDA: 10.43

Growth

Rev 1Y: 20.38%

Income Statement (TTM)

Revenue: $311.51M
Gross Margin: 90.36%
Operating Expenses: $130.72M
Operating Income: $150.75M
Net Profit: $314.11M

Balance Sheet

Rev 1Y Fwd Est

16.68%

Rev 3Y (CAGR)

28.30%

Rev 5Y (CAGR)

41.38%

Rev 10Y (CAGR)

103.27%

EPS 1Y

5075.00%

EPS 1Y Fwd Est

-54.40%

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $179.83M
Working Capital: $441.43M
Total Assets: $792.26M
Net Debt: -$119.41M
Total Liabilities: $177.4M
Total Equity: $614.86M

Cash Flow Statement (TTM)

Cash Flow from Operations: $173.75M
Cash Flow from Investing: $12.42M
Cash Flow from Financing: -$59.65M
Free Cash Flow: $173.58M
Capital Expenditures: $173.59K